Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system

Methotrexate (MTX) is an essential anti-rheumatic drug used to treat rheumatoid arthritis (RA). Prevention or management of adverse reactions, including interstitial lung disease (ILD), hepatotoxicity, myelosuppression, and infection, remains fundamental for safe MTX therapy. Using the Food and Drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Onda, Kenji, Honma, Takeshi, Masuyama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992735/
https://www.ncbi.nlm.nih.gov/pubmed/36909171
http://dx.doi.org/10.3389/fphar.2023.1030832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992735/
https://www.ncbi.nlm.nih.gov/pubmed/36909171
http://dx.doi.org/10.3389/fphar.2023.1030832

Ejemplares similares